Become a Member

Zoetis Inc. (ZTS)

Healthcare • Drug Manufacturers - Specialty & Generic

48
Beobachten
$125,56
Price
-0,86%
Change
55,33 Mrd. $
Market Cap
-
P/E Ratio

Neumann-Score Stock Analysis

48
out of 100
Beobachten
Valuation??/100
Profitability??/100
Growth??/100

Unlock Score Details

Become a member and get access to all analyses.

Become a Member

About Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise ...

CEO
Kristin C. Peck
Employees
13.800
Country
US